Dinopol, Cres John A.

HRN: 22-95-33  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/24/2023
METRONIDAZOLE 125MG/5ML, 60ML (BOT)
04/24/2023
05/02/2023
PO
11.5
TID
Amoebiasis
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Intra-abdominal    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: